IDH2 and acute myeloid leukemia: Further studies should be carried out to dissect in detail the complex effects of 2-HG on leukemic cells and on healthy bone marrow cells, and its role in the response of AML blasts to therapies, thus improving the management of R/R AML with mutated IDH enzymes.